![[Podcast] Behind the Breakthroughs: How Almac Powers Clinical Trial Success with Care](https://imgproxy.divecdn.com/5lAJkli_KcGt1FSsw4EaegjgP76IHREqYEWbhNBJOXw/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9CaW9QaGFybWFEaXZlXzEzNDZfeF83MjlfQXJ0d29yay5qcGc=.webp)
.jpg)
Lotus advances Kayelekera towards third-quarter production
Refurbishment and restart works at ASX-listed Lotus Resources’s Kayelekera uranium project, in Malawi, continue to progress as planned, with first uranium production on track for the third quarter of this year. Overall, mechanical and electrical progress is over 80% complete, with all key operational roles now appointed and a restart workforce of more than 300 local and expat personnel on site.
Refurbishment and restart works at ASX-listed Lotus Resources’s Kayelekera uranium project, in Malawi, continue to progress as planned, with first uranium production on track for the third quarter of this year. Overall, mechanical and electrical progress is over 80% complete, with all key operational roles now appointed and a restart workforce of more than 300 local and expat personnel on site.
